|
|
Pharmaceutical Product Developme News (NASDAQ:PPDI)
| Latest Pharmaceutical Product Development News Headlines | | Date | Time | Source | | | 10/22/2008 | 9:20AM | PRNUS | Beacon Equity Issues Technical Trade Alerts on Medical Laboratories and Research Stocks: DGX, ERES, LH, PPDI, BRLI, CVD
DALLAS, Oct. 22 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today.
Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m
Today's Trade Alerts include: Quest Diagnostics Inc. (NYSE:DGX), eResearch Technology Inc. (NASDAQ:ERES... More...>> |
| 10/03/2008 | 5:20PM | PRNUS | BetterInvesting Magazine Releases December's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educa
MADISON HEIGHTS, Mich., Oct. 3 /PRNewswire-USNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Pharmaceutical Product Development, Inc. (NASDAQ:PPDI) as its December 2008 "Stock to Study" and eBay Inc. (NASDAQ:EBAY) as its December "Undervalued Stock" for... More...>> |
| 06/24/2008 | 8:00AM | PRNUS | PPD Accelerates Clinical Trial Data Collection and Reporting With Oracle(R) Remote Data Capture 4.5.3
Oracle and PPD Build on Long-Standing Relationship to Deliver Faster, Easier-to-Use Application at Clinical Trial Investigative Sites
BOSTON, June 24 /PRNewswire-FirstCall/ -- DIA 44th Annual meeting --
-- Today, Oracle and PPD, Inc. (NASDAQ:PPDI), a leading global contract research organization (CRO), announced that... More...>> |
| 03/31/2008 | 4:07PM | PRNUS | PPD Names Mike Wilkinson Executive Vice President of Global Clinical Development
WILMINGTON, N.C., March 31 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) today announced it has appointed Mike Wilkinson, Ph.D., as executive vice president of global clinical development. In this role, he will provide strategic leadership to the company's Phase II-IV operations in North America; Latin America;... More...>> |
| 02/28/2008 | 4:07PM | PRNUS | PPD Confirms Takeda's NDA Filing of Alogliptin with U.S. Food and Drug Administration
Triggers $15 million milestone payment
WILMINGTON, N.C., Feb. 28 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) today confirmed that Takeda Pharmaceutical Company Limited's new drug application (NDA) for alogliptin, a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, has been accepted for filing... More...>> |
| 02/25/2008 | 9:00AM | PRNUS | Aton Pharma Announces the Appointment of Dr. Fred Eshelman to Management Board
LAWRENCEVILLE, N.J., Feb. 25 /PRNewswire/ -- Aton Pharma, Inc., a global specialty pharmaceutical company, announced today that Dr. Fred Eshelman has joined the management board of Aton's parent company, Princeton Pharma Holdings LLC. Dr. Eshelman is the founder, Vice Chairman and CEO of Pharmaceutical Product Development... More...>> |
| 02/22/2008 | 9:24AM | PRNUS | PPD Declares First Quarter Dividend
WILMINGTON, N.C., Feb. 22 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) today announced that its board of directors declared a cash dividend for the first quarter of 2008 under its annual cash dividend policy. The quarterly cash dividend will equal $0.10 per share. The record date for the first quarter dividend... More...>> |
| 02/20/2008 | 4:06PM | PRNUS | PPD Announces Plan to Repurchase Shares of its Common Stock
WILMINGTON, N.C., Feb. 20 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) today announced its plans to begin a stock repurchase program whereby up to $350 million of its common stock may be purchased from time to time in the open market.
The company made the decision to initiate a share repurchase program in view... More...>> |
| 02/06/2008 | 4:31PM | PRNUS | PPD to Acquire InnoPharm Ltd.
Strengthening PPD's presence in Eastern Europe
WILMINGTON, N.C., Feb. 6 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) today announced it has signed an agreement to purchase InnoPharm Ltd., an independent contract research organization, or CRO, based in Smolensk, Russia. The acquisition will expand PPD's global reach... More...>> |
| 02/06/2008 | 4:26PM | PRNUS | PPD Reports Fourth Quarter and Year-End 2007 Financial Results
Highlights:
WILMINGTON, N.C., Feb. 6 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) today reported its financial and operating results for the fourth quarter and full year ended December 31, 2007.
PPD recorded net revenue of $375.0 million for the fourth quarter of 2007, an increase of 15.0 percent over net revenue... More...>> |
| 01/23/2008 | 4:06PM | PRNUS | PPD Expands Global Central Lab Services into China
WILMINGTON, N.C., Jan. 23 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) today announced that it has expanded its global central lab services into China through an exclusive agreement with Peking Union Lawke Biomedical Development Limited (PUL). The agreement allows PPD to begin immediately providing biopharmaceutical... More...>> |
| 01/10/2008 | 4:36PM | PRNUS | PPD Announces Fourth Quarter and Year-End 2007 Earnings Release, Webcast and Conference Call
WILMINGTON, N.C., Jan. 10 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) will release its fourth quarter and year-end 2007 financial results on Wednesday, February 6, 2008, after the market closes. The earnings release will be available on the PPD Web site at http://www.ppdi.com/, FirstCall and PR Newswire.
On Thursday... More...>> |
| 01/10/2008 | 4:10PM | PRNUS | CSS Informatics Signs Solutions Partner Agreement with Nimbus Partners
Business process management supports success in technology-focused projects
WILMINGTON, N.C., Jan. 10 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) today announced that CSS Informatics, the clinical and safety data management consulting services and proprietary e-technologies division of PPD, has entered into a... More...>> |
| 01/08/2008 | 4:27PM | PRNUS | PPD Updates 2007 Forecast; Issues Financial Guidance for 2008
Highlights:
WILMINGTON, N.C., Jan. 8 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) today updated its existing 2007 guidance and reported its projected financial guidance for 2008.
PPD anticipates that net revenue, excluding reimbursed out-of-pocket expenses, for the full year 2007 will be in range of $1.295 to... More...>> |
| 01/02/2008 | 4:10PM | PRNUS | PPD Names Senior Vice President for Europe, Middle East and Africa
Strengthens global leadership in drug development
WILMINGTON, N.C., Jan. 2 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) today announced the appointment of Sebastian Pacios, M.D., as senior vice president of clinical operations for Europe, Middle East and Africa (EMEA). In this role, Dr. Pacios will oversee Phase... More...>> |
| 12/12/2007 | 4:22PM | PRNUS | Mathew to Lead PPD Drug Development Operations and Expansion in India
Company announces second office in Mumbai
WILMINGTON, N.C., Dec. 12 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) today announced the appointment of Philip Mathew, M.D., as director of strategic development, to lead the company's Phase II-IV operations and expansion in India.
Dr. Mathew will provide strategic leadership... More...>> |
| 12/11/2007 | 1:40PM | PRNUS | PPD Announces 2008 Financial Guidance Webcast and Conference Call
WILMINGTON, N.C., Dec. 11 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) will release its fiscal year 2008 financial guidance on Tuesday, January 8, 2008, after the market closes. The release will be available on the PPD Web site at http://www.ppdi.com/, FirstCall and PR Newswire.
On Wednesday, January 9, 2008... More...>> |
| 11/27/2007 | 4:00PM | PRNUS | Viramontes to Lead PPD Clinical Operations in Mexico, Central America and the Caribbean
WILMINGTON, N.C., Nov. 27 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) today announced the appointment of Jose Luis Viramontes, M.D., as associate director of clinical operations, to lead the company's delivery of drug development services in Mexico, Central America and the Caribbean. Based in Mexico City, Dr... More...>> |
| 11/14/2007 | 4:32PM | PRNUS | PPD Declares Fourth Quarter Dividend
WILMINGTON, N.C., Nov. 14 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) today announced that its board of directors declared a cash dividend for the fourth quarter of 2007 under its annual cash dividend policy. As recently announced, the board of directors amended the annual cash dividend policy to increase the... More...>> |
| 10/23/2007 | 4:27PM | PRNUS | PPD Opens Offices in Sydney, Australia; Copenhagen, Denmark; Lima, Peru; and Lisbon, Portugal
Expands global footprint for drug development services
WILMINGTON, N.C., Oct. 23 /PRNewswire-FirstCall/ -- PPD, Inc. (NASDAQ:PPDI) today announced the opening of offices in Sydney, Australia; Copenhagen, Denmark; Lisbon, Portugal; and Lima, Peru; reflecting continued expansion of its Phase II-IV services in key therapeutic... More...>> |
|
|
|